INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 277
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Meant Health

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Personalized GLP-1 medication + full supplement stack + private Care Coaching.' 'The Meant Triple Stack.' Locked-in pricing: 'Your price stays the same when your dose goes up.' Supplement kit 'worth up to $1,449' included free.

Audienceread

US consumers seeking GLP-1 weight loss who value price predictability and coaching support.

Pricing & termssnapshot

Compounded semaglutide Triple Stack from $179/mo ($1,698 stated value); compounded tirzepatide Triple Stack from $269/mo ($1,788 stated value). Locked-in pricing across dose increases.

Clinical relationshipspartial

Telehealth prescribing plus private 1:1 certified care coach. Site claims LegitScript certification (badge shown; registry not independently checked).

Pharmacy & fulfillmentpartial

Compounded semaglutide/tirzepatide; pharmacy not named on reviewed pages.

Advertising snapshotpartial

No attributable ads found in Google, Meta or LinkedIn public libraries on 20 Oct 2026; generic brand-word queries return unrelated results. See dated channel evidence.

Founding yearpartial

Launched Aug 2026 per company PRNewswire releases; expanded to FDA-approved brands (Ozempic) Sep 2026.

Foundersnot_found

Not found in this pass.

    Location & entity contextnot_found

    Not stated on pages reviewed.

      Search visibility samplenot_found

      Not assessed in this pass.

        THE MODERN DOSING WEEKLY

        The peptide news
        that changes your week.

        Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.